Provided by Tiger Trade Technology Pte. Ltd.

Arrowhead Pharmaceuticals

82.38
-0.2500-0.30%
Volume:244.74K
Turnover:20.18M
Market Cap:11.60B
PE:-36.07
High:83.38
Open:81.58
Low:80.33
Close:82.63
52wk High:95.49
52wk Low:27.94
Shares:140.86M
Float Shares:122.00M
Volume Ratio:0.36
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2838
EPS(LYR):-0.0122
ROE:-55.21%
ROA:-8.10%
PB:24.93
PE(LYR):-6,756.34

Loading ...

Dec 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 26, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 26, 2025

Major Issues Report

Form 8-K - Current report
Nov 18, 2025

Major Issues Report

Form 8-K - Current report
Oct 10, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Oct 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 12, 2025

Major Issues Report

Form 8-K - Current report
Sep 11, 2025

Major Issues Report

Form 8-K - Current report
Sep 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 02, 2025

Major Issues Report

Form 8-K - Current report
Aug 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 13, 2025

Major Issues Report

Form 8-K - Current report
May 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]